Therma Bright Inc
XTSX:THRM
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
|
Therma Bright Inc
XTSX:THRM
|
4m CAD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
189.2B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
137.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
135.6B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
133.3B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.7B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.1B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.8B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36.7B USD |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
Therma Bright Inc
Glance View
Therma Bright, Inc. develops and markets skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is a developer of the AcuVid COVID-19 Rapid Antigen Saliva Test and other diagnostic and medical device technologies that help test for illnesses and assist with pain management. The firm is focused on providing consumers and medical professionals with solutions that addresses medical and healthcare challenges. The company also provides a technology that delivers non-invasive, and pain-free skincare. Its product offerings include AcuVid, which is an antigen and antibody rapid screening test for COVID-19; Venowave, is a Deep Vein Thrombosis (DVT) prevention pump specifically designed for use at home; InterceptCS, is a system that provides controlled topical heat without the risk of burning the skin; Benepod, is a hot and cold contrast therapy device for pain relief without pain relieving medication, and TherOZap, provides pain management relief using thermal therapy for insect bites and stings.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Therma Bright Inc is 65.3%, which is below its 3-year median of 82.6%.
Over the last 3 years, Therma Bright Inc’s Gross Margin has increased from 39.6% to 65.3%. During this period, it reached a low of 39.6% on Oct 1, 2022 and a high of 100% on Oct 31, 2023.
